FDAnews Drug Daily Bulletin

VIRAGEN ANNOUNCES RESEARCH COLLABORATION WITH PROMINENT BIODEFENSE CONSULTANT TO U.S.

May 10, 2006
A A

Viragen, Inc. today announced that the Company has entered into a research collaboration agreement with AFG BioSolutions, Inc., a prominent biodefense consultant to the U.S. federal government. Maryland-based AFG BioSolutions has agreed to conduct in vivo research studies using Multiferon (natural, human alpha interferon) to evaluate its utility as a broad-acting anti-viral agent against a variety of biological threats such as smallpox and other biowarfare viral threat agents.
Yahoo News